Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils

Current Biology

Volumn 7, Issue 11, 1997, Pages 836-843

  Gerber, B O ^a   Zanni, M P ^b   Uguccioni, M ^a   Loetscher, M ^a   Mackay, C R ^c   Pichler, W J ^b   Yawalkar, N ^b   Baggiolini, M ^a   Moser, B ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031282530     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(06)00371-X     Document Type: Article

References (46)

1. Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 1994, 55:97-179.
2. Baggiolini M, Dewald B, Moser B: Human chemokines: an update. Annu Rev Immunol 1997, 15:675-705.
3. Premack BA, Schall TJ: Chemokine receptors: gateways to inflammation and infection. Nature Med 1996, 2:1174-1178.
4. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD: Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Med 1996, 2:449-456.
5. Ponath PD, Qin SX, Ringler DJ, dark-Lewis I, Wang J, Kassam N, et al.: Cloning of the human eosinophil chemoattractant, eotaxin - expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996, 97:604-612.
6. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA: RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992, 176:1489-1495.
7. Alam R, Stafford S, Forsythe P, Harrison R, Faubion D, Lett-Brown MA, Grant JA: RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993, 150:3442-3447.
8. Weber M, Uguccioni M, Ochensberger B, Baggiolini M, Clark-Lewis I, Dahinden CA: Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. J Immunol 1995, 154:4166-4172.
9. Dahinden CA, Geiser T, Brunner T, von Tscharner V, Caput D, Ferrara P, et al.: Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med 1994, 179:751-756.
10. Uguccioni M, Loetscher P, Forssmann U, Dewald B, Li HD, Lima SH, et al.: Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J Exp Med 1996, 183:2379-2384.
11. Griffiths-Johnson DA, Collins PD, Rossi AG, Jose PJ, Williams TJ: The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun 1993, 197:1167-1172.
12. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, et al.: Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994, 179:881-887.
13. Jose PJ, Adcock IM, Griffiths-Johnson DA, Berkman N, Wells TNC, Williams TJ, Power CA: Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem Biophys Res Commun 1994, 205:788-794.
14. Rothenberg ME, Luster AD, Leder P: Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci USA 1995, 92:8960-8964.
15. Combadiere C, Ahuja SK, Murphy PM: Cloning and functional expression of a human eosinophil CC chemokine receptor. J Biol Chem 1995, 270:16491-16494.
16. Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, Springer MS: Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med 1996, 183:2349-2354.
17. Ponath PD, Qin SX, Post TW, Wang J, Wu L, Gerard NP, et al.: Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 1996, 183:2437-2448.
18. Murphy PM: Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Fact Rev 1996, 7:47-64.
19. Moser B, Loetscher M, Piali L, Loetscher P: Lymphocyte responses to chemokines. Int Rev Immunol, in press.
20. Stellato C, Collins P, Ponath PD, Soler D, Newman W, La Rosa G, et al.: Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest 1997, 99:926-936.
21. Yamada H, Hirai K, Miyamasu M, Iikura M, Misaki Y, Shoji S, et al.: Eotaxin is a potent chemotaxin for human basophils. Biochem Biophys Res Commun 1997, 231:365-368.
22. Uguccioni M, Mackay CR, Ochsenberger B, Loetscher P, Rhis S, LaRosa G, et al.: High expression of the cheokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 1997, 100:1137-1143.
23. Rothenberg ME, Luster AD, Lilly CM, Drazen JM, Leder P: Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J Exp Med 1995, 181:1211-1216.
24. Gonzalo JA, Lloyd CM, Kremer L, Finger E, Martinez C, Siegelman MH, et al.: Eosinophil recruitment to the lung in a murine model of allergic inflammation - the role of T cells, chemokines, and adhesion receptors. J Clin Invest 1996, 98:2332-2345.
25. Gonzalo JA, Jia G, Aguirre V, Friend D, Coyle AJ, Jenkins NA, et al.: Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity 1996, 4:1-14.
26. Rothenberg ME, MacLean JA, Pearlman E, Luster AD, Leder P: Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med 1997, 185:785-790.
27. Qin SX, LaRosa G, Campbell JJ, Smith-Heath H, Kassam N, Shi XJ, et al.: Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential. Eur J Immunol 1996, 26:640-647.
28. Loetscher P, Seitz M, Baggiolini M, Moser B: Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 1996, 184:569-577.
29. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, et al.: Chemokine receptor specific for IP10 and Mig: Structure, function, and expression in activated T-lymphocytes. J Exp Med 1996, 184:963-969.
30. De Weck AL: Drugs as allergens. J Allergy Clin Immunol 1986, 78:1047-1059.
31. Zanni MP, Mauri-Hellweg D, Brander C, Wendland T, Schnyder B, Frei E, von Greyerz S, Bircher A, Pichler WJ: Characterization of lidocaine-specific T cells. J Immunol 1997, 158:1139-1148.
32. Heath H, Qin SX, Rao P, Wu LJ, LaRosa G, Kassam N, et al.: Chemokine receptor usage by human eosinophils - the importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest 1997, 99:178-184.
33. Charo IF, Myers SJ, Herman A, Franci C, Connolly AJ, Coughlin SR: Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA 1994, 91:2752-2756.
34. Pdolsky DK: Inflammatory bowel disease (second of two parts). W Engl J Med 1991, 325:1008-1015.
35. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol 1994, 10:587-593.
36. Peveri P, Walz A, Dewald B, Baggiolini M: A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988, 167:1547-1559.
37. Uguccioni M, D'Apuzzo M, Loetscher M, Dewald B, Baggiolini M: Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β on human monocytes. Eur J Immunol 1995, 25:64-68.
38. Colotta F, Peri G, Villa A, Mantovani A: Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. J Immunol 1984, 132:936-944.
39. Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, Pichler WJ: Direct, MHC-dependent presentation of the drug sulfamethoxazole to human αβ T cell clones. J Clin Invest 1997, 100:136-141.
40. Wyss-Coray T, Brander C, Frutig K, Pichler WJ: Discrimination of human CD4 T cell clones based on their reactivity with antigen-presenting T cells. Eur J Immunol 1992, 22:2295-2302.
41. Lanzavecchia A: Antigen-specific interaction between T and B cells. Nature 1985, 314:537-539.
42. + T lymphocytes in bulous cutaneous reactions caused by β-lactam antibiotics. J Invest Dermatol 1993, 101:794-799.
43. von Tscharner V, Prod'hom B, Baggiolini M, Reuter H: Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration. Nature 1986, 324:369-372.
44. Ulfgren A-K, Lindblad S, Klareskog L, Andersson J, Andersson U: Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 1995, 54:654-661.
45. Van der Loos C, Becker AE, van den Oord JJ: Practical suggestions for successful immunoenzyme double-staining experiments. Histochem J 1993, 25:1-13.
46. Romagnani S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994, 12:227-257.